This trial will examine the acute effects of CBD on the brain. 100% THC-free CBD will be compared to placebo, and participants will be scanned before and after ingestion. Results will help to determine if CBD has any neurometabolic or neurophysiological effects, and if it affects working memory or response inhibition.
8 Primary · 0 Secondary · Reporting Duration: Collected pre-drug, post-drug, pre-placebo, and post-placebo; through study completion (4 time points over a 72 hour period)
15 Total Participants · 2 Treatment Groups
Primary Treatment: Cannabidiol · Has Placebo Group · N/A
Age 18 - 65 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|Did not meet criteria||50.0%|
|18 - 65||100.0%|